Wilson Lewis Mandala

Prof. Wilson Lewis Mandala


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2010 in Science
Verified
Journal Article
Closed access
PDF file
CMCalman A. MacLennan
Calman A. MacLennan
JGJames J. Gilchrist
James J. Gilchrist
MGMelita A. Gordon
Melita A. Gordon
ACAdam F. Cunningham
Adam F. Cunningham
MCMark Cobbold
Mark Cobbold
MMMalcolm E. Molyneux
Malcolm E. Molyneux
HIV and Salmonella: HIV-positive individuals who are infected with nontyphoidal strains of Salmonella enterica often succumb to high morbidity and mortality. Why this is the case is unknown. MacLennan et al. (p. 508 ; see the Perspective by Moir and Fauci ) have uncovered a dysregulated antibody response to Salmonella that is the likely culprit. Sera from HIV-infected individuals do a poor job of killing S. Typhimurium, despite surprisingly elevated antibody titers. Experiments showed that HIV-infected serum inhibited the power of normal serum to kill Salmonella . Inhibition was specific to antibodies against lipopolysaccharide (LPS), a component of the cell wall of Salmonella . Hence, HIV-infected sera was able to kill Salmonella strains lacking LPS, and removing LPS immunoglobulin G from infected sera permitted Salmonella killing. Thus, not only does HIV cause defects in cell-mediated immunity but it also seems to impair humoral immunity, with severe consequences for multiple infections.

1 November 2017 in Cell Host & Microbe
Verified
Journal Article
Closed access
AKAnne Kessler
Anne Kessler
SDSelasi Dankwa
Selasi Dankwa
MBMaria Bernabeu
Maria Bernabeu
VHVisopo Harawa
Visopo Harawa
SDSamuel A. Danziger
Samuel A. Danziger
KKKami Kim
Kami Kim

1 April 2017 in Clinical and Vaccine Immunology
Verified
Journal Article
Open access
WMWilson Lewis Mandala
Wilson Lewis Mandala
CMChisomo Lawrence Msefula
Chisomo Lawrence Msefula
EGEsther N. Gondwe
Esther N. Gondwe
MDMark T. Drayson
Mark T. Drayson
MMMalcolm E. Molyneux
Malcolm E. Molyneux
CMCalman A. MacLennan
Calman A. MacLennan
Proinflammatory cytokines are involved in clearance ofPlasmodium falciparum, and very high levels of these cytokines have been implicated in the pathogenesis of severe malaria. In order to determine how cytokines vary with disease severity and syndrome, we enrolled Malawian children presenting with cerebral malaria (CM), severe malarial anemia (SMA), and uncomplicated malaria (UCM) and healthy controls. We analyzed serum cytokine concentrations in acute infection and in convalescence. With the exception of interleukin 5 (IL-5), cytokine concentrations were highest in acute CM, followed by SMA, and were only mildly elevated in UCM. Cytokine concentrations had fallen to control levels when remeasured at 1 month of convalescence in all three clinical malaria groups. Ratios of IL-10 to tumor necrosis factor alpha (TNF-α) and of IL-10 to IL-6 followed a similar pattern. Children presenting with acute CM had significantly higher concentrations of TNF-α (P< 0.001), interferon gamma (IFN-γ) (P= 0.0019), IL-2 (P= 0.0004), IL-6 (P< 0.001), IL-8 (P< 0.001), and IL-10 (P< 0.001) in sera than healthy controls. Patients with acute CM had significantly higher concentrations of IL-6 (P< 0.001) and IL-10 (P= 0.0003) than those presenting with acute SMA. Our findings are consistent with the concept that high levels of proinflammatory cytokines, despite high levels of the anti-inflammatory cytokine IL-10, could contribute to the pathogenesis of CM.

1 May 2008 in Food Chemistry
Verified
Journal Article
Closed access
POP. Okinda Owuor
P. Okinda Owuor
MOMartin Obanda
Martin Obanda
HNHastings E. Nyirenda
Hastings E. Nyirenda
WMWilson Lewis Mandala
Wilson Lewis Mandala

16 January 2014 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
TNTonney S. Nyirenda
Tonney S. Nyirenda
JGJames J. Gilchrist
James J. Gilchrist
NFNicholas A. Feasey
Nicholas A. Feasey
SGSarah J. Glennie
Sarah J. Glennie
NBNaor Bar-Zeev
Naor Bar-Zeev
RHRobert Heyderman
Robert Heyderman
Background. Salmonella Typhimurium (STm) remain a prominent cause of bacteremia in sub-Saharan Africa. Complement-fixing antibodies to STm develop by 2 years of age. We hypothesized that STm-specific CD4+ T cells develop alongside this process. Methods. Eighty healthy Malawian children aged 0–60 months were recruited. STm-specific CD4+ T cells producing interferon γ, tumor necrosis factor α, and interleukin 2 were quantified using intracellular cytokine staining. Antibodies to STm were measured by serum bactericidal activity (SBA) assay, and anti-STm immunoglobulin G antibodies by enzyme-linked immunosorbent assay. Results. Between 2006 and 2011, STm bacteremias were detected in 449 children <5 years old. STm-specific CD4+ T cells were acquired in infancy, peaked at 14 months, and then declined. STm-specific SBA was detectable in newborns, declined in the first 8 months, and then increased to a peak at age 35 months. Acquisition of SBA correlated with acquisition of anti–STm–lipopolysaccharide (LPS) immunoglobulin G (r = 0.329 [95% confidence interval, .552–.062]; P = .01) but not anti–STm–outer membrane protein or anti–STm-flagellar protein (FliC). Conclusions. Acquisition of STm-specific CD4+ T cells in early childhood is consistent with early exposure to STm or cross-reactive protein antigens priming this T-cell development. STm-specific CD4+ T cells seem insufficient to protect against invasive nontyphoidal Salmonella disease, but sequential acquisition of SBA to STm LPS is associated with a decline in its incidence.

28 October 2021 in Current Research in Immunology
Verified
Journal Article
Open access
WMWilson Lewis Mandala
Wilson Lewis Mandala
VHVisopo Harawa
Visopo Harawa
AMAlinane Munyenyembe
Alinane Munyenyembe
MSMonica Soko
Monica Soko
HLHerbert Longwe
Herbert Longwe
Cell-mediated responses to immunological stimuli are often localised in inflammatory sites and involve a number of cell types. These responses can be functionally characterised at the single-cell level on the basis of the types of cytokines expressed either in whole blood or PBMCs. The ability to measure antigen-specific cell responses at the single cell level is an important tool with a wide range of potential applications ranging from studies of disease pathogenesis to the evaluation of vaccines.